Oak Ridge Investments LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oak Ridge Investments LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 69.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,021 shares of the medical equipment provider’s stock after buying an additional 6,961 shares during the quarter. Oak Ridge Investments LLC’s holdings in Intuitive Surgical were worth $8,884,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Hazlett Burt & Watson Inc. increased its stake in shares of Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after acquiring an additional 20 shares in the last quarter. Fragasso Financial Advisors Inc increased its position in Intuitive Surgical by 3.0% during the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after purchasing an additional 20 shares during the period. Ullmann Wealth Partners Group LLC raised its holdings in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares in the last quarter. Finally, Meeder Advisory Services Inc. lifted its position in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after purchasing an additional 22 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 over the last 90 days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.5 %

ISRG opened at $592.64 on Friday. The stock has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The firm has a 50 day moving average price of $540.66 and a 200-day moving average price of $498.77. Intuitive Surgical, Inc. has a twelve month low of $362.14 and a twelve month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Truist Financial boosted their target price on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.